Serum Institute to invest £240 million to expand its vaccine business in UK

Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.

Important takeaways for all competitive exams:

• The SII was founded by Cyrus Poonawalla (Adar Poonawalla’s father) in 1966.
• Adar Poonawalla joined the Serum Institute of India in 2001 and became the CEO of the company in 2011.

Find More National News Here